1. |
Altmann C, Schmidt MHH. The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration[J]. Int J Mol Sci, 2018, 19(1): 110. DOI: 10.3390/ijms19010110.
|
2. |
Simó R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter?[J]. Diabetologia, 2018, 61(9): 1902-1912. DOI: 10.1007/s00125-018-4692-1.
|
3. |
Li F, Jiang D, Samuel MA. Microglia in the developing retina[J]. Neural Dev, 2019, 14(1): 12. DOI: 10.1186/s13064-019-0137-x.
|
4. |
Zhou T, Huang Z, Sun X, et al. Microglia polarization with M1/M2 phenotype changes in rd1 mouse model of retinal degeneration[J]. Front Neuroanat, 2017, 11: 77. DOI: 10.3389/fnana.2017.00077.
|
5. |
Zeng HL, Shi JM. The role of microglia in the progression of glaucomatous neurodegeneration-a review[J]. Int J Ophthalmol, 2018, 11(1): 143-149. DOI: 10.18240/ijo.2018.01.22.
|
6. |
刘然, 晏颖, 陈晓. 去小胶质细胞化对糖尿病小鼠视网膜光感受器细胞的影响[J]. 眼科新进展, 2020, 40(12): 1114-1118. DOI: 10.13389/j.cnki.rao.2020.0248.Liu R, Yan Y, Chen X. Effects of deletion microglia on retinal photoreceptor cells in diabetic mice[J]. Rec Adv Ophthalmol, 2020, 40(12): 1114-1118. DOI: 10.13389/j.cnki.rao.2020.0248.
|
7. |
Lv Z, Guo Y. Metformin and its benefits for various diseases[J]. Front Endocrinol (Lausanne), 2020, 11: 191. DOI: 10.3389/fendo.2020.00191.
|
8. |
Lin HC, Stein JD, Nan B, et al. Association of geroprotective effects of metformin and risk of open-angle glaucoma in persons with diabetes mellitus[J]. JAMA Ophthalmol, 2015, 133(8): 915-923. DOI: 10.1001/jamaophthalmol.2015.1440.
|
9. |
Qu S, Zhang C, Liu D, et al. Metformin protects ARPE-19 cells from glyoxal-induced oxidative stress[J/OL]. Oxid Med Cell Longev, 2020: 1740943[2020-07-09]. https://pubmed.ncbi.nlm.nih.gov/32695253/. DOI: 10.1155/2020/1740943.
|
10. |
A L, Zou T, He J, et al. Rescue of retinal degeneration in rd1 mice by intravitreally injected metformin[J]. Front Mol Neurosci, 2019, 12: 102. DOI: 10.3389/fnmol.2019.00102.
|
11. |
Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states[J]. Br J Pharmacol, 2016, 173(4): 649-665. DOI: 10.1111/bph.13139.
|
12. |
Jin Q, Cheng J, Liu Y, et al. Improvement of functional recovery by chronic metformin treatment is associated with enhanced alternative activation of microglia/macrophages and increased angiogenesis and neurogenesis following experimental stroke[J]. Brain Behav Immun, 2014, 40: 131-142. DOI: 10.1016/j.bbi.2014.03.003.
|
13. |
Le W, Rowe D, Xie W, et al. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease[J]. J Neurosci, 2001, 21(21): 8447-8455. DOI: 10.1523/JNEUROSCI.21-21-08447.2001.
|
14. |
Arroba AI, Alcalde-Estevez E, García-Ramírez M, et al. Modulation of microglia polarization dynamics during diabetic retinopathy in db/db mice[J]. Biochim Biophys Acta, 2016, 1862(9): 1663-1674. DOI: 10.1016/j.bbadis.2016.05.024.
|
15. |
Chen J, Sun Z, Jin M, et al. Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway[J]. J Neuroimmunol, 2017, 305: 108-114. DOI: 10.1016/j.jneuroim.2017.02.010.
|
16. |
Liu T, Zhang L, Joo D, et al. NF-κB signaling in inflammation[J/OL]. Signal Transduct Target Ther, 2017, 2: e17023[2017-07-14]. https://pubmed.ncbi.nlm.nih.gov/29158945/. DOI: 10.1038/sigtrans.2017.23.
|
17. |
Zhou T, Huang Z, Zhu X, et al. Alpha-1 antitrypsin attenuates M1 microglia-mediated neuroinflammation in retinal degeneration[J/OL]. Front Immunol, 2018, 9: 1202[2018-05-30]. https://pubmed.ncbi.nlm.nih.gov/29899745/. DOI: 10.3389/fimmu.2018.01202.
|
18. |
Manwani B, McCullough LD. Function of the master energy regulator adenosine monophosphate activated protein kinase in stroke[J]. J Neurosci Res, 2013, 91(8): 1018-1029. DOI: 10.1002/jnr.23207.
|